Skip to main content
OpenTrials
Completed

NCT Number: NCT03090399

Fluid ORiented Therapy for yoUNg Asa 1patients

In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemodynamics

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA 1

Exclusion criteria

  • cardiac diseases
  • pulmonary diseases
  • renal diseases
  • metabolic disorders

Treatment and study plan

FloTrac

Device

For patients belonging to case group a Pulse Contour Analysis was adopted for optimize fluid administration

Primary outcomes

  1. prevalence of complications

    Time frame: up to 30 days

Secondary outcomes

  1. days of hospitalization

    Time frame: up to 12 weeks

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Registry information

Official study title

Effects of the Goal-directed Fluid Therapy on ASA 1 Patients Scheduled for Intensive Debulking Surgery

Important dates

Study start
2012
Primary completion
2015
Study completion
2017
First posted
Mar 24, 2017
Registry last updated
Mar 24, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.